Please find attached herewith financial results for the year ended 31st March, 2026
INDOAMIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 2.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Amines Ltd reported strong full-year results with standalone revenue from operations growing 5.8% to Rs 1,11,797 lakh from Rs 1,05,658 lakh. Net profit after tax jumped nearly 30% to Rs 7,977 lakh compared to Rs 6,140 lakh in the previous year. On a consolidated basis, revenue reached Rs 1,15,966 lakh and PAT was Rs 7,933 lakh, up 41.9% YoY. Operating margin expanded from 11.2% to 13.3% on standalone basis. The Board recommended a final dividend of Rs 0.50 per share (10% on face value Rs 5). Additionally, the company granted 5,60,000 stock options to eligible employees under the ESOP 2025 plan. The statutory auditor issued an unmodified (clean) opinion on both standalone and consolidated results.
The company delivered robust profit growth exceeding 25% with margin expansion, which should be positive for shareholders. Clean audit opinion and dividend declaration indicate financial health. The stock option grant may have mild dilution impact going forward.